Eculizumab is a monoclonal antibody. Eculizumab binds to proteins in the blood that can destroy red blood cells in people with genetic conditions that affect the natural defenses of red blood cells. Eculizumab is used to prevent the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinemia (PNH). Eculizumab is also used to treat a rare chronic blood disease called atypical hemolytic uremic syndrome (aHUS) Eculizumab may also be used for purposes not listed in this medication guide.
Soliris is medicine used by physicians to treat a certain type of blood disease. Soliris medicine is a humanized monoclonal antibody that provides approved therapy for treatment of the said blood condition. The generic name for Soliris is Eculizumab. Solirisis approved by the FDA for the treatment ofvarious other diseases and is under investigations as a possible drug for treatment of other rare conditions.